GSA Capital Partners LLP Acquires 5,056 Shares of Cigna Group $CI

GSA Capital Partners LLP grew its holdings in shares of Cigna Group (NYSE:CI) by 311.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,680 shares of the health services provider’s stock after buying an additional 5,056 shares during the quarter. GSA Capital Partners LLP’s holdings in Cigna Group were worth $1,842,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Russell Investments Group Ltd. lifted its position in Cigna Group by 2.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 844,481 shares of the health services provider’s stock valued at $233,023,000 after acquiring an additional 19,937 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its holdings in Cigna Group by 8.8% during the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 206,656 shares of the health services provider’s stock worth $56,971,000 after purchasing an additional 16,725 shares in the last quarter. ANTIPODES PARTNERS Ltd bought a new stake in Cigna Group during the 2nd quarter worth approximately $34,000. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund raised its stake in shares of Cigna Group by 12.6% in the second quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 139,448 shares of the health services provider’s stock worth $38,443,000 after purchasing an additional 15,560 shares during the last quarter. Finally, Keystone Financial Services purchased a new stake in shares of Cigna Group in the second quarter worth approximately $204,000. 86.99% of the stock is owned by institutional investors.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CI has been the topic of several analyst reports. Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Piper Sandler lowered their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Cantor Fitzgerald raised their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Royal Bank Of Canada lifted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Finally, Guggenheim upped their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Stock Performance

NYSE CI opened at $282.24 on Monday. The company has a market capitalization of $74.58 billion, a PE ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a 50-day simple moving average of $286.02 and a 200 day simple moving average of $281.28.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the firm earned $7.20 EPS. The company’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, research analysts predict that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.